Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Iopofosine I 131 single dose Phase 2 Results Expected
Iopofosine I 131 single dose • Waldenstrom Macroglobulinemia
Target Indication
Waldenstrom Macroglobulinemia
Clinical Trial
NCT02952508Last updated: 12/4/2025